Mounjaro price: $499 a month at every dose without insurance
Mounjaro single-dose pens cost $499 per four weeks at every dose through LillyDirect. The list price is $1,112.16. Mounjaro is approved for type 2 diabetes. Zepbound contains the same medicine, tirzepatide, is approved for chronic weight management, and costs less on self-pay: $299 at 2.5 mg.
By the Tirzepatide Price data desk · Prices checked 21 Nov 2026 · How we rank
We earn a commission from some sellers when you use our links. It does not change the price you pay or the order of our lists. How we make money
| Route | Price per fill | |
|---|---|---|
| LillyDirectMounjaro single-dose pensSame price at every dose. Mounjaro is approved for type 2 diabetes. Checked 21 Nov 2026. | $499 | View offer at LillyDirect, opens in a new tab |
| TrumpRx.govMounjaro single-dose pens, filled by LillyDirectSame price at every dose. Mounjaro is approved for type 2 diabetes. Checked 21 Nov 2026. | $499 | View offer at TrumpRx.gov, opens in a new tab |
| Mounjaro Savings CardMounjaro, insurance covers MounjaroAs little as $25 per fill. Savings capped at $150 per 1-month fill. Commercial insurance only. Mounjaro is approved for type 2 diabetes. Checked 21 Nov 2026. | $25 | View offer at Mounjaro Savings Card, opens in a new tab |
| Mounjaro Savings CardMounjaro, insurance does not cover MounjaroAs low as $499 per 28-day fill. Savings capped at $647 a month and $8,411 a calendar year. Commercial insurance only. Checked 21 Nov 2026. | $499 | View offer at Mounjaro Savings Card, opens in a new tab |
Common questions
How much is Mounjaro without insurance?
$499 per four weeks at any dose through LillyDirect or with Lilly's savings card when your commercial plan does not cover it, checked 21 Nov 2026.
Is Mounjaro cheaper than Zepbound?
Not on self-pay. Zepbound is $299 to $449 depending on dose; Mounjaro is $499 at every dose. With insurance that covers the drug, either can be $25 with its savings card.
Can I get Mounjaro for weight loss?
Mounjaro's FDA-approved use is type 2 diabetes. Zepbound is the tirzepatide product approved for chronic weight management. Which is right for you is a question for your clinician.